08.01.2012
The statistic shows the market value of the top 10 biotech and pharmaceutical companies in 2010. In 2010, Johnson & Johnson had a market value of 179.7 billion dollars.
http://www.statista.com
more13.12.2011
Merck Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announced the launch of the Muse Cell Analyzer system for real-time quantitative assessment of cell concentration, cell health, apoptosis, and cell cycle with greater accuracy and precision than manual hemocytometry or image-based automated analysis.
more29.11.2011
Scientists can now take that "a-ha" moment to go with a method Princeton University researchers developed - and successfully tested - to speed up the chances of an unexpected yet groundbreaking chemical discovery.
more01.08.2011
Top 10 Pharma Companys: Total revenue (in blue -Umsatz (german)) and expenses for R&D (in grey (Ausgaben Forschung und Entwicklung (german)) worldwide in 2010 (*in US$ billions).
For example Pfizer had a total revenue of about US$ 58.6 billion, and invested about US$ 9.41 billion in R&D.
Source: Diverse Sources (Company Information), Pharmaceutical Executive
© Statista 2011
more16.03.2011
The High-Throughput Sample Preparation System called Samplicity Filtration System, an innovative new technology that provides a convenient, high throughput alternative to syringe-tip filters when preparing the samples for chromatography, was introduced at Pittcon 2011 by EMD Millipore the Life Science division of Merck KGaA of Germany.
more01.12.2010
Merck KGaA has reached two important milestones in European chemicals legislation. First, approximately 100 substances have been registered by December 1st within the scope of the REACH Regulation. Second, 4,200 substances have been classified and labeled in accordance with the CLP Regulation and provided with new Material Safety Data Sheets in line with the revised Annex II of the REACH Regulation.
more23.11.2010
Evotec announced that it has signed within the "NEU²-Consortium" framework and partially funded by the Federal Ministry of Education and Research (Bundesministerium fuer Bildung und Forschung - BMBF), an agreement with Merck KGaA, Darmstadt, Germany, to develop pre-clinical candidates for an undisclosed neurological disease. Evotec will provide drug discovery expertise covering in vitro biology, medicinal chemistry and in vitro and in vivo pharmacology.
more29.10.2010
Merck KGaA announced that it will sell Théramex, its Monaco-based pharmaceutical company specialized in women's health and gynecology, to Teva. Merck and Teva have signed an agreement whereby Teva will acquire all Théramex operations including 100% of the shares of Théramex S.A.M of Monaco and Théramex S.p.A. of Italy for a consideration of EUR 265 million. In addition, Merck will be eligible to receive certain performance-based milestone payments.
more27.10.2010
European ScreeningPort, a Hamburg based service provider to academics for early drug discovery - set up as an innovative public private partnership entity - announced that it has entered into an agreement with Merck KGaA, Darmstadt, Germany, as part of the New Drugs Fighting Neurological Diseases Consortium (NEU²).
more19.10.2010
Hydrophilic interaction chromatography (HILIC) [1] has been described as a useful alternative to reversed-phase chromatography for polar compounds that not are retained on conventional C18 columns. In the HILIC mode of separation, a mixture of organic and aqueous solvents are used as mobile phase in combination with polar stationary phases [2-4], such as ion exchange, amino, silica, diol, zwitterion to obtain retention of highly polar compounds. Silica columns intended for HILIC are commercially available and provided by several manufacturers.
more